CMPX
NASDAQ · Biotechnology

Compass Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$1.38
-0.44 (-24.18%)
As of Sep 22, 2:01 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +3,796.4% upside
Low Target $36.32
Average Target $53.77
High Target $66.75
Current Price $1.38
Current
$1.38
Target
$53.77
$36.32 $53.77 avg $66.75
Scenario Analysis
Bear Case
$36.32
2,531.9%
Low target
Base Case
$53.77
+3,796.4%
Avg target
Bull Case
$66.75
+4,737.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.88
-79.9% from high
52-Week Low
$1.61
+-14.3% from low
Target vs 52W High
$53.77
+681.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%